Management of COVID-19 in special populations with kidney disease

Radhakrishnan, Yeshwanter; Hassanein, Mohamed; Stephany, Brian

doi:10.3949/ccjm.87a.ccc067

Cited by 3 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ventilation [ 36 , 40 , 75 ] and terminal disinfection of the room including equipment and supplies was advised between two dialysis shifts [ 35 , 38 , 67 , 75 , 78 , 94 ]. One percent diluted bleach (sodium hypochlorite) was used for floor and surface disinfection and 10% diluted bleach or 70% alcohol for areas contaminated with patient secretions [ 53 , 56 , 72 , 73 , 75 ]; instead, nebulizing hydrogen peroxide was used for room decontamination [ 12 ].…”

Section: Resultsmentioning

confidence: 99%

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

et al. 2021

View full text Add to dashboard Cite

Background Patients undergoing in-centre haemodialysis (HD) are particularly exposed to the dire consequences of COVID-19. The present systematic scoping review aims to identify the extent, range, and nature of articles related to COVID-19 and maintenance HD: it reports specifically the prevalence of the COVID-19 pandemic in the HD population, implementation of strategies for the prevention, mitigation and containment of the COVID-19 pandemic in HD centres, demographic and clinical characteristics, and outcomes of the pediatric and adult HD patients. Methods A multi-step systematic search of the literature in Pubmed, Scopus, Ovid Medline, Embase and Web of Science, published between December 1, 2019, and January 30, 2021 was performed. Two authors separately screened the titles and abstracts of the documents and ruled out irrelevant articles. A report of the papers that met inclusion criteria was performed; then, a descriptive analysis of the characteristics of the included articles and a narrative synthesis of the results were performed. Results The review process ended with the inclusion of 145 articles. Most of them were based on single-centre experiences, which spontaneously developed best practices. Most studies were conducted in high-income countries (69.7%) and a part of them (9.6%) were not in English. Prevalence of COVID-19 among dialysis patients accounted for 0%-37.6%. Preventive measures were reported in 54% of the included articles, with particular emphasis on education, triage, hygiene, and containment measures. Patients experienced a heterogeneous spectrum of symptoms that led 35%-88.2% of them to hospital admission. Median and mean hospital length of stay ranged from 8 to 28.5 and 16.2 to 22 days, respectively. Admission to intensive care units varied widely across studies (from 2.6% to 70.5%) and was associated with high mortality (42.8%-100%). Overall, prognosis was poor in 0%-47% of the hospitalized patients. Conclusions This systematic scoping review provides an overview of the current knowledge on the impact of COVID-19 on the frail world of HD patients. Furthermore, it may help to implement the existing strategies of COVID-19 prevention and provide a list of unmet needs (safe transport, testing, shelter). Finally, it may be a stimulus for performing systematic reviews and meta-analyses which will form the basis for evidence-based guidelines.

show abstract

Section: Resultsmentioning

confidence: 99%

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Among renal patients on haemodialysis, global mortality ranges from 23% to 30.5%, mainly in elderly patients and in those who have been dependent on treatment for a longer time. According to data from the available literature, one of every four patients on dialysis with COVID-19 will not survive [6,7]. This is why, for this group of patients and their healthcare providers, the greatest efforts must be directed at prevention, strengthening all structural biosecurity measures and all logistical stages related to their treatment, including transfers from and to medical centers [8].…”

Section: Introductionmentioning

confidence: 99%

Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2

Aroca¹,

SA²,

Vélez-Verbel³

et al. 2021

Int J Nephrol Kidney Fail

View full text Add to dashboard Cite

Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.

show abstract

A short review on impact of Covid-19 in diabetic chronic kidney disease patients

Singh¹

2022

IJNMHS

View full text Add to dashboard Cite

Patients with diabetes and chronic kidney disease including end-stage kidney disease, and kidney transplant recipients are at increased risk of severe COVID-19 infection, hospitalization and premature death. Both diabetes and CKD exert synergistic effect on increasing the patient’s susceptibility towards risk of COVID-19 infection. The Global Burden of Disease collaboration (GBD) and WHO have declared CKD and diabetes as the most prevalent risk factors for severe COVID-19. Hence, management should focus on both infection prevention and treatment. Several studies and adequate evidence from literature is available on the impact of COVID-19 disease on diabetes alone or CKD alone. However, many data is not available on COVID-19 disease impact on diabetic CKD patients. This short review article focuses on understanding the impact of COVID-19 on diabetic CKD patients and other aspects such as pathophysiology, epidemiology, prevention and management of diabetic CKD patients with COVID-19 infection.

show abstract

Management of COVID-19 in special populations with kidney disease

Cited by 3 publications

References 15 publications

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2

A short review on impact of Covid-19 in diabetic chronic kidney disease patients

Contact Info

Product

Resources

About